Cutler Group LP Igm Biosciences, Inc. Call Options Transaction History

Cutler Group LP

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Jul 18, 2023	BUY	$8.86 - $14.0 $17,720 - $28,000	2,000 New	2,000 $3,000
Q4 2022 Feb 07, 2023	SELL	$15.45 - $26.02 $18,540 - $31,224	-1,200 Reduced 92.31%	100 $0
Q3 2022 Oct 25, 2022	BUY	$15.42 - $27.01 $13,878 - $24,309	900 Added 225.0%	1,300 $4,000
Q2 2022 Aug 04, 2022	SELL	$13.27 - $25.5 $1.17 Million - $2.25 Million	-88,300 Reduced 99.55%	400 $0
Q1 2022 Apr 14, 2022	BUY	$13.42 - $29.73 $1.17 Million - $2.6 Million	87,500 Added 7291.67%	88,700 $123,000
Q4 2021 Jan 18, 2022	BUY	$27.59 - $66.39 $33,108 - $79,668	1,200 New	1,200 $2,000

21.4M

39.5K

16.5K

Ticker IGMS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,969,000
Market Cap $500M
Description
IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.